Suchergebnisse - "Dauden, E."

PubPharm (288)

1

Translated article] The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis

enthalten in: Actas dermo-sifiliograficas | 2024

von González-Domínguez, A. | García-Agua, N. | Dauden, E. | +1

2

The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis

enthalten in: Actas dermo-sifiliograficas | 2024

von González-Domínguez, A. | García-Agua, N. | Dauden, E. | +1

3

Comparing the Use of Topical Therapy Along with Anti-IL-17 and Anti-IL-23 to Treat Moderate-to-Severe Psoriasis in the Routine Clinical Practice

enthalten in: Actas dermo-sifiliograficas | 2024

von Berenguer-Ruiz, S. | Romero-Dávila, M. | Aparicio-Domínguez, M. | +3

4

Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment : Real-World Data From Clinical Practice in Spain

enthalten in: Actas dermo-sifiliograficas | 2024

von Daudén, E. | Vidal, D. | Romero, A. | +10

5

Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment : Real-World Data From Clinical Practice in Spain

enthalten in: Actas dermo-sifiliograficas | 2024

von Daudén, E. | Vidal, D. | Romero, A. | +10

6

Effectiveness of secukinumab for the treatment of erythrodermic psoriasis : Multicentre study in daily practice

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Reymundo, A. | Armesto, S. | Rodríguez, L. | +6

7

Persistence and effectiveness of guselkumab treatment in patients with moderate-to-severe plaque psoriasis in a non-interventional real-world setting : The SPRING study

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Puig, L. | Daudén, E. | Cuervas-Mons, M. | +2

8

Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome : post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2022

von Fernandez, A. | Dauden, E. | Gerdes, S. | +13

9

Effectiveness and safety profile of secukinumab for the treatment of patients with generalized pustular psoriasis in daily practice

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2022

von Reymundo, A. | Vilarrasa, E. | Baniandrés, O. | +4

10

Moderate to Severe Psoriasis in Pediatric and Young Patients : The BIOBADADERM Registry Experience

enthalten in: Actas dermo-sifiliograficas | 2022

von Nieto Benito, L. | Carretero, G. | Rivera-Díaz, R. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]